3-bromo-N-[(4-methoxyphenyl)methyl]-N-methyl-4-[2-[4-(trifluoromethoxy)phenyl]ethyl]benzenesulfonamide
C24H23BrF3NO4S — CID 159993628
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-bromo-N-[(4-methoxyphenyl)methyl]-N-methyl-4-[2-[4-(trifluoromethoxy)phenyl]ethyl]benzenesulfonamide
3-bromo-N-[(4-methoxyphenyl)methyl]-N-methyl-4-[2-[4-(trifluoromethoxy)phenyl]ethyl]benzenesulfonamide (PubChem CID 159993628) has the molecular formula C24H23BrF3NO4S and a molecular weight of 558.42 g/mol. Its IUPAC name is 3-bromo-N-[(4-methoxyphenyl)methyl]-N-methyl-4-[2-[4-(trifluoromethoxy)phenyl]ethyl]benzenesulfonamide.
Molecular Properties
| Compound Name | 3-bromo-N-[(4-methoxyphenyl)methyl]-N-methyl-4-[2-[4-(trifluoromethoxy)phenyl]ethyl]benzenesulfonamide |
|---|---|
| PubChem CID | 159993628 |
| Molecular Formula | C24H23BrF3NO4S |
| Molecular Weight | 558.42 g/mol |
| Exact Mass | 557.05 |
| IUPAC Name | 3-bromo-N-[(4-methoxyphenyl)methyl]-N-methyl-4-[2-[4-(trifluoromethoxy)phenyl]ethyl]benzenesulfonamide |
| SMILES | COc1ccc(CN(C)S(=O)(=O)c2ccc(CCc3ccc(OC(F)(F)F)cc3)c(Br)c2)cc1 |
| InChI | InChI=1S/C24H23BrF3NO4S/c1-29(16-18-6-10-20(32-2)11-7-18)34(30,31)22-14-9-19(23(25)15-22)8-3-17-4-12-21(13-5-17)33-24(26,27)28/h4-7,9-15H,3,8,16H2,1-2H3 |
| InChIKey | OHGOUBQUMGAPFR-UHFFFAOYSA-N |
| XLogP | 5.96 |
| TPSA | 55.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 558.42 |
| LogP ≤ 5 | 5.96 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159993628 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.